• OPEN AN ACCOUNT
Indian Indices
Sensex
82,225.92 -1,068.74
( -1.28%)
Global Indices
Nasdaq
49,202.49 377.42
(0.77%)
Dow Jones
6,910.52 51.77
(0.75%)
Hang Seng
57,337.44 511.74
(0.90%)
Nikkei 225
10,686.70 1.96
(0.02%)
Forex
USD-INR
90.72 -0.31
(-0.34%)
EUR-INR
106.89 -0.33
(-0.31%)
GBP-INR
122.26 -0.41
(-0.34%)
JPY-INR
0.59 0.00
(-0.41%)

EQUITY - MARKET SCREENER

Lyka Labs Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
500259
INE933A01014
37.0210703
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
LYKALABS
0
218.17
EPS(TTM)
Face Value()
Div & Yield %
0
10
0
 
( Cr)
ParticularsDec 2025 ( Cr)Sep 2025 ( Cr)Jun 2025 ( Cr)
Gross Sales30.7332.9729.18
Other Operating Income0.000.000.00
Other Income 1.261.210.67
Total Income31.9934.1929.84
Total Expenditure 28.8236.1225.79
PBIDT3.17-1.944.06
Interest 0.820.790.85
PBDT2.35-2.733.20
Depreciation2.082.072.03
Tax0.000.180.31
Fringe Benefit Tax0.000.000.00
Deferred Tax0.00-1.350.05
Reported Profit After Tax0.28-3.630.81
Extra-ordinary Items 0.000.000.00
Adjusted Profit After Extra-ordinary item0.28-3.630.81
EPS (Unit Curr.)0.08-1.020.22
EPS (Adj) (Unit Curr.)0.08-1.020.22
Calculated EPS (Unit Curr.)0.08-1.020.23
Calculated EPS (Adj) (Unit Curr.)0.08-1.020.23
Calculated EPS (Ann.) (Unit Curr.)0.31-4.060.91
Calculated EPS (Adj) (Ann.) (Unit Curr.)0.31-4.060.91
Book Value (Unit Curr.)0.000.000.00
Dividend (%)0.000.000.00
Equity35.6935.6935.69
Reserve & Surplus0.000.000.00
Face Value10.0010.0010.00
Public Shareholding (No. Of Shares)0.000.000.00
Public Shareholding (% in Equity)0.000.000.00
Pledged/Encumbered - No. of Shares0.000.000.00
Pledged/Encumbered - % in Total Promoters Holding0.000.000.00
Pledged/Encumbered - % in Total Equity0.000.000.00
Non Encumbered - No. of Shares0.000.000.00
Non Encumbered - % in Total Promoters Holding0.000.000.00
Non Encumbered - % in Total Equity0.000.000.00
PBIDTM(%)10.32-5.8813.91
PBDTM(%)7.65-8.2810.97
PATM(%)0.91-11.012.78